
                                SEQUENCE LISTING

<110> SQZ BIOTECHNOLOGIES COMPANY

<120> METHODS TO STIMULATE IMMUNE RESPONSES TO MUTANT RAS
      USING ANUCLEATE CELLS

<130> 75032-20027.40

<140> Not Yet Assigned
<141> Concurrently Herewith

<150> US 63/058,438
<151> 2020-07-29

<160> 17

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 1
Met Thr Glu Tyr Lys Leu Val Val Val Gly Ala Asp Gly Val Gly Lys
 1               5                  10                  15      


<210> 2
<211> 18
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 2
Thr Glu Tyr Lys Leu Val Val Val Gly Ala Asp Gly Val Gly Lys Ser
 1               5                  10                  15      
Ala Leu
        


<210> 3
<211> 21
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 3
Thr Glu Tyr Lys Leu Val Val Val Gly Ala Asp Gly Val Gly Lys Ser
 1               5                  10                  15      
Ala Leu Thr Ile Gln
            20      


<210> 4
<211> 28
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 4
Thr Glu Tyr Lys Leu Val Val Val Gly Ala Asp Gly Val Gly Lys Ser
 1               5                  10                  15      
Ala Leu Thr Ile Gln Leu Ile Gln Asn His Phe Val
            20                  25              


<210> 5
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 5
Met Thr Glu Tyr Lys Leu Val Val Val Gly Ala Val Gly Val Gly Lys
 1               5                  10                  15      


<210> 6
<211> 18
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 6
Thr Glu Tyr Lys Leu Val Val Val Gly Ala Val Gly Val Gly Lys Ser
 1               5                  10                  15      
Ala Leu
        


<210> 7
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 7
Glu Tyr Lys Leu Val Val Val Gly Ala Val Gly Val Gly Lys Ser
 1               5                  10                  15  


<210> 8
<211> 40
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 8
Glu Tyr Lys Leu Val Val Val Gly Ala Val Gly Val Gly Lys Ser Ala
 1               5                  10                  15      
Leu Thr Ile Gln Leu Ile Gln Asn His Phe Val Asp Glu Tyr Asp Pro
            20                  25                  30          
Thr Ile Glu Asp Ser Tyr Arg Lys
        35                  40  


<210> 9
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 9
Val Val Val Gly Ala Asp Gly Val Gly Lys
 1               5                  10  


<210> 10
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 10
Val Val Val Gly Ala Val Gly Val Gly Lys
 1               5                  10  


<210> 11
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 11
Val Val Val Gly Ala Cys Gly Val Gly Lys
 1               5                  10  


<210> 12
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 12
Val Val Gly Ala Asp Gly Val Gly Lys
 1               5                  


<210> 13
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 13
Val Val Gly Ala Val Gly Val Gly Lys
 1               5                  


<210> 14
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 14
Lys Leu Val Val Val Gly Ala Asp Gly Val
 1               5                  10  


<210> 15
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 15
Gly Ala Asp Gly Val Gly Lys Ser Ala Leu
 1               5                  10  


<210> 16
<211> 20
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 16
tccatgacgt tcctgacgtt                                             20

<210> 17
<211> 24
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 17
tcgtcgtttt gtcgttttgt cgtt                                        24

